Ecovyst (ECVT) Deutsche Bank 34th Annual Leveraged Finance Conference Presentation summary
Event summary combining transcript, slides, and related documents.
Deutsche Bank 34th Annual Leveraged Finance Conference Presentation summary
30 Sep, 2026Business profile and strategy
Leading provider of regenerated and virgin sulfuric acid, sulfur dioxide, and derivatives, with strong positions in North America and proprietary technology.
Exposure to growth sectors such as mining, electronics, and North American re-industrialization.
Over 90% of 2025 sales secured by contracts with raw material cost pass-through and minimum volume protections.
Strategic acquisitions, including Calabrian and Waggaman, have expanded product offerings and market reach.
Focus on operational excellence, supply chain reliability, and high-quality customer relationships.
Product and service offerings
Supplies regenerated and virgin sulfuric acid, sulfur dioxide, sodium bisulfite, sodium thiosulfate, and sodium metabisulfite.
Products serve key industries: refining, mining, water treatment, energy, food, and specialty chemicals.
Leading ex-situ catalyst activation services through Chem32.
Manufacturing sites strategically located near major customers in the US and Canada.
Financial performance and capital allocation
Q2 2026 sales reached $250 million, with Adjusted EBITDA of $53 million and Adjusted Free Cash Flow of $13 million.
Adjusted EBITDA margin was 21.2%, down 260 bps year-over-year, mainly due to higher sulfur costs and inflation.
Net debt leverage ratio at 2.0x as of June 30, 2026, with $176 million in liquidity.
$146 million share repurchase authorization remaining; $35.7 million repurchased YTD June 2026.
Over the past 15 months, 60% of capital allocated to debt repayment, 29% to acquisitions, and 11% to share repurchases.
Latest events from Ecovyst
- Strong Q2 2026 results reflect market leadership in sulfur solutions and disciplined capital allocation.ECVT
Conference presentation - Q2 2026 sales up 42%, net income doubled, and guidance raised after Calabrian acquisition.ECVT
Q2 2026 - Q1 2025 sales reached $162 million with strong catalyst growth and stable leverage.ECVT
BMO Chemicals 2025 Conference presentation - Q1 2024 delivered higher margins, strong cash flow, and growth in sustainable catalyst markets.ECVT
2024 Wells Fargo Industrials Conference presentation - Q2 2025 sales rose, margins faced pressure, and strategic focus remains on sustainable growth.ECVT
Jefferies 2025 Industrials Conference presentation - Q3 2025 delivered robust sales and EBITDA, with post-divestiture leverage expected below 1.5x.ECVT
Citi 2025 Basic Materials Conference presentation - Q1 2026 saw robust sales and margin growth, supported by strategic expansion and strong cash flow.ECVT
BMO Chemicals 2026 Conference presentation - Q1 2025 sales stable, margins pressured, Zeolyst JV drives catalyst segment growth.ECVT
DB 15th Annual Global Industrials, Materials & Building Products Conference presentation - Q1 2026 delivered strong sales and EBITDA growth, driven by expanded sulfur solutions and robust demand.ECVT
Wells Fargo Industrials Conference presentation